Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilie De Muynck

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Chemistry and Laboratory Medicine|December 12, 2024
Use of labile HbA<sub>1c</sub> as a screening tool to minimize clinical misinterpration of HbA<sub>1c</sub>Emilie De Muynck, Bruno Lapauw, Joris Delanghe, et al.
Journal of the Belgian Society of Radiology|January 31, 2020
CT Perfusion as a Selection Tool for Mechanical Thrombectomy, a Single-Centre StudyEmilie De Muynck, Vincent Huybrechts, Dimitri Hemelsoet, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 2023
VIDAS3® TB-IGRA assay: evaluation of performance characteristics in a predominantly low risk, low incidence populationAnnelies De Bel, Annelies Brouwers, Frederick Verbeke, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 19, 2024
Early detection of OXA-48 producing Klebsiella pneumoniae with the use of rapid antibiotic susceptibility testingEmilie De Muynck, Stien Vandendriessche, Anne-Sophie Messiaen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 25, 2025
Impact of reporting rapid susceptibility results in Gram negative bloodstream infections: a real world prospective studyAnne-Sophie Messiaen, Stien Vandendriessche, Emilie De Muynck, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Chemistry and Laboratory Medicine|December 12, 2024
Use of labile HbA<sub>1c</sub> as a screening tool to minimize clinical misinterpration of HbA<sub>1c</sub>Emilie De Muynck, Bruno Lapauw, Joris Delanghe, et al.
Journal of the Belgian Society of Radiology|January 31, 2020
CT Perfusion as a Selection Tool for Mechanical Thrombectomy, a Single-Centre StudyEmilie De Muynck, Vincent Huybrechts, Dimitri Hemelsoet, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 2023
VIDAS3® TB-IGRA assay: evaluation of performance characteristics in a predominantly low risk, low incidence populationAnnelies De Bel, Annelies Brouwers, Frederick Verbeke, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 19, 2024
Early detection of OXA-48 producing Klebsiella pneumoniae with the use of rapid antibiotic susceptibility testingEmilie De Muynck, Stien Vandendriessche, Anne-Sophie Messiaen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 25, 2025
Impact of reporting rapid susceptibility results in Gram negative bloodstream infections: a real world prospective studyAnne-Sophie Messiaen, Stien Vandendriessche, Emilie De Muynck, et al.
Pageof 1